442 related articles for article (PubMed ID: 30932744)
1. The Role of Visceral Adiposity Index Levels in Predicting the Presence of Metabolic Syndrome and Insulin Resistance in Overweight and Obese Patients.
Pekgor S; Duran C; Berberoglu U; Eryilmaz MA
Metab Syndr Relat Disord; 2019 Jun; 17(5):296-302. PubMed ID: 30932744
[No Abstract] [Full Text] [Related]
2. Can Visceral Adiposity Index Serve as a Simple Tool for Identifying Individuals with Insulin Resistance in Daily Clinical Practice?
Štěpánek L; Horáková D; Cibičková Ľ; Vaverková H; Karásek D; Nakládalová M; Zapletalová J
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31470593
[No Abstract] [Full Text] [Related]
3. Visceral Adiposity Index (VAI) in Children and Adolescents with Obesity: No Association with Daily Energy Intake but Promising Tool to Identify Metabolic Syndrome (MetS).
Vizzuso S; Del Torto A; Dilillo D; Calcaterra V; Di Profio E; Leone A; Gilardini L; Bertoli S; Battezzati A; Zuccotti GV; Verduci E
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33525454
[TBL] [Abstract][Full Text] [Related]
4. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
Durmus U; Duran C; Ecirli S
J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
[TBL] [Abstract][Full Text] [Related]
5. Central adiposity markers, plasma lipid profile and cardiometabolic risk prediction in overweight-obese individuals.
Barazzoni R; Gortan Cappellari G; Semolic A; Ius M; Zanetti M; Gabrielli A; Vinci P; Guarnieri G; Simon G
Clin Nutr; 2019 Jun; 38(3):1171-1179. PubMed ID: 29779870
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of various body indices and visceral adiposity index in predicting metabolic syndrome among Chinese patients with adult growth hormone deficiency.
Qing L; Wei R; Chan L; Xiaoya Z; Xin X
J Endocrinol Invest; 2017 Jun; 40(6):653-661. PubMed ID: 28233232
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the ability of HOMA-IR, VAI, and TyG indexes to predict metabolic syndrome in children with obesity: a cross-sectional study.
Dundar C; Terzi O; Arslan HN
BMC Pediatr; 2023 Feb; 23(1):74. PubMed ID: 36765298
[TBL] [Abstract][Full Text] [Related]
8. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome.
de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW
Metab Syndr Relat Disord; 2021 Feb; 19(1):18-25. PubMed ID: 32845813
[No Abstract] [Full Text] [Related]
9. Metabolic syndrome and Visceral Adiposity Index in non-functional adrenal adenomas.
Karatas S; Hacioglu Y; Beysel S
Arch Endocrinol Metab; 2023 Mar; 67(3):323-329. PubMed ID: 36468929
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Blood Pressure and Visceral Adiposity on the Association of Serum Uric Acid With Albuminuria in Adults Without Full Metabolic Syndrome.
Krajcoviechova A; Tremblay J; Wohlfahrt P; Bruthans J; Tahir MR; Hamet P; Cifkova R
Am J Hypertens; 2016 Dec; 29(12):1335-1342. PubMed ID: 27565787
[TBL] [Abstract][Full Text] [Related]
11. Association Between the Visceral Adiposity Index and Homeostatic Model Assessment of Insulin Resistance in Participants With Normal Waist Circumference.
Ji B; Qu H; Wang H; Wei H; Deng H
Angiology; 2017 Sep; 68(8):716-721. PubMed ID: 28743220
[TBL] [Abstract][Full Text] [Related]
12. Positively increased visceral adiposity index in hyperuricemia free of metabolic syndrome.
Gu D; Ding Y; Zhao Y; Miao S; Qu Q
Lipids Health Dis; 2018 May; 17(1):101. PubMed ID: 29734946
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of a new anthropometric indicator - VAI (Visceral Adiposity Index) in the evaluation of metabolic and hormonal disorders in women with polycystic ovary syndrome.
Brończyk-Puzoń A; Jagielski P; Kulik-Kupka K; Koszowska A; Nowak J; Zubelewicz-Szkodzińska B
Adv Clin Exp Med; 2017 Aug; 26(5):825-828. PubMed ID: 29068579
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of the metabolic syndrome criteria as predictors of insulin resistance among obese Korean women.
Lee K
Public Health Nutr; 2010 Feb; 13(2):181-6. PubMed ID: 19706218
[TBL] [Abstract][Full Text] [Related]
15. Can "VAI" Better Indicate Metabolic Syndrome Compared with Other Metabolic Syndrome-Related Parameters in Patients with Thyroid Nodules? A Study from Turkey.
Durcan E; Sahin S; Dedeoglu SE; Ozkaya HM; Gonen MS
Metab Syndr Relat Disord; 2021 Aug; 19(6):358-366. PubMed ID: 33794138
[No Abstract] [Full Text] [Related]
16. Association of the Triglyceride to High-Density Lipoprotein Ratio and the Visceral Adiposity Index with Metabolic Syndrome in Diabetic Susceptible Population.
Huang W; Shu L; Zhao H; Chen S; Zhang H; Song G
Horm Metab Res; 2020 Feb; 52(2):95-103. PubMed ID: 32053842
[TBL] [Abstract][Full Text] [Related]
17. The association of the visceral adiposity index with insulin resistance and beta-cell function in Korean adults with and without type 2 diabetes mellitus.
Sung HH; Park CE; Gi MY; Cha JA; Moon AE; Kang JK; Seong JM; Lee JH; Yoon H
Endocr J; 2020 Jun; 67(6):613-621. PubMed ID: 32161204
[TBL] [Abstract][Full Text] [Related]
18. Role of body composition and metabolic profile in Barrett's oesophagus and progression to cancer.
Di Caro S; Cheung WH; Fini L; Keane MG; Theis B; Haidry R; Di Renzo L; De Lorenzo A; Lovat L; Batterham RL; Banks M
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):251-60. PubMed ID: 26671515
[TBL] [Abstract][Full Text] [Related]
19. Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors.
Barrea L; Muscogiuri G; Modica R; Altieri B; Pugliese G; Minotta R; Faggiano A; Colao A; Savastano S
Front Endocrinol (Lausanne); 2021; 12():649496. PubMed ID: 33815296
[TBL] [Abstract][Full Text] [Related]
20. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.
Ercin CN; Dogru T; Genc H; Celebi G; Aslan F; Gurel H; Kara M; Sertoglu E; Tapan S; Bagci S; Rizzo M; Sonmez A
Metab Syndr Relat Disord; 2015 Sep; 13(7):319-25. PubMed ID: 26011302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
